KR20230113742A - 난소암의 검출 및 치료를 위한 방법 - Google Patents
난소암의 검출 및 치료를 위한 방법 Download PDFInfo
- Publication number
- KR20230113742A KR20230113742A KR1020237017397A KR20237017397A KR20230113742A KR 20230113742 A KR20230113742 A KR 20230113742A KR 1020237017397 A KR1020237017397 A KR 1020237017397A KR 20237017397 A KR20237017397 A KR 20237017397A KR 20230113742 A KR20230113742 A KR 20230113742A
- Authority
- KR
- South Korea
- Prior art keywords
- ovarian cancer
- subject
- das
- n3ap
- diacspmd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G01N33/57449—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107160P | 2020-10-29 | 2020-10-29 | |
| US63/107,160 | 2020-10-29 | ||
| PCT/US2021/056852 WO2022093960A1 (en) | 2020-10-29 | 2021-10-27 | Methods for the detection and treatment of ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230113742A true KR20230113742A (ko) | 2023-08-01 |
Family
ID=81383153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237017397A Pending KR20230113742A (ko) | 2020-10-29 | 2021-10-27 | 난소암의 검출 및 치료를 위한 방법 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240044902A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4237090B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023548110A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230113742A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116490776A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196725A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022093960A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4558824A4 (en) * | 2022-07-21 | 2026-07-08 | Univ Texas | METHODS OF DETECTION AND TREATMENT OF OVARIAN CANCER |
| KR20250017689A (ko) | 2023-07-27 | 2025-02-04 | 가톨릭대학교 산학협력단 | 난소암 발병 위험률 예측 방법 및 분석장치 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004081569A1 (ja) * | 2003-03-11 | 2004-09-23 | Trans Genic Inc. | 腫瘍マーカーとしてのn1,n12-ジアセチルスペルミン |
| JP2007502983A (ja) * | 2003-08-15 | 2007-02-15 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | がん検出のための多因子アッセイ |
| EP2046344A2 (en) * | 2006-07-14 | 2009-04-15 | MannKind Corporation | Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes |
| WO2009006439A1 (en) * | 2007-06-29 | 2009-01-08 | Correlogic Systems, Inc. | Predictive markers for ovarian cancer |
| CN108508168B (zh) * | 2012-02-23 | 2021-08-17 | 学校法人庆应义塾 | 并用抗癌剂的感受性判定标记 |
| WO2013188391A2 (en) * | 2012-06-11 | 2013-12-19 | Georgia Regents University | Biomarkers for ovarian cancer |
| GB201316347D0 (en) * | 2013-09-13 | 2013-10-30 | Cancer Rec Tech Ltd | Biological fluid filtration assembly |
| US20160282351A1 (en) * | 2013-10-28 | 2016-09-29 | Salivatech Co., Ltd. | Salivary biomarkers for cancers, methods and devices for assaying the same, and methods for determining salivary biomarkers for cancers |
| CA2933005C (en) * | 2015-06-12 | 2024-01-23 | Brock University | Methods and compounds for enhancing contrast in magnetic resonance imaging (mri) |
| TW201800408A (zh) * | 2016-06-15 | 2018-01-01 | 拜耳製藥公司 | Mps-1抑制劑 |
| HRP20240136T1 (hr) * | 2016-06-29 | 2024-04-12 | Tesaro, Inc. | Metode liječenja raka jajnika |
| ES2995959T3 (en) * | 2017-02-09 | 2025-02-11 | Univ Texas | Methods for the detection and treatment of lung cancer |
| WO2019178216A1 (en) * | 2018-03-13 | 2019-09-19 | Baylor Research Institute | Methods and compositions for treating, diagnosing, and prognosing ovarian cancer |
| JP7272627B2 (ja) * | 2019-01-24 | 2023-05-12 | 公立大学法人和歌山県立医科大学 | 卵巣腫瘍の評価用バイオマーカー |
| CN109870579B (zh) * | 2019-02-03 | 2022-02-11 | 辽宁迈迪生物科技股份有限公司 | 单克隆抗体保护液及制备方法和应用、应用单克隆抗体保护液的试剂与免疫组化试剂盒 |
-
2021
- 2021-10-27 EP EP21887441.0A patent/EP4237090B1/en active Active
- 2021-10-27 WO PCT/US2021/056852 patent/WO2022093960A1/en not_active Ceased
- 2021-10-27 CA CA3196725A patent/CA3196725A1/en active Pending
- 2021-10-27 KR KR1020237017397A patent/KR20230113742A/ko active Pending
- 2021-10-27 CN CN202180073446.5A patent/CN116490776A/zh active Pending
- 2021-10-27 JP JP2023525978A patent/JP2023548110A/ja active Pending
-
2023
- 2023-04-10 US US18/297,979 patent/US20240044902A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240044902A1 (en) | 2024-02-08 |
| EP4237090A4 (en) | 2024-09-25 |
| CA3196725A1 (en) | 2022-05-05 |
| CN116490776A (zh) | 2023-07-25 |
| EP4237090A1 (en) | 2023-09-06 |
| WO2022093960A1 (en) | 2022-05-05 |
| EP4237090B1 (en) | 2026-02-18 |
| JP2023548110A (ja) | 2023-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108957006B (zh) | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 | |
| US20220042998A1 (en) | Biomarkers for pancreatic cancer | |
| CN108603887B (zh) | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 | |
| US20240159753A1 (en) | Methods for the detection and treatment of lung cancer | |
| WO2021076036A1 (en) | Apparatuses and methods for detection of pancreatic cancer | |
| US20160188835A1 (en) | Biomarkers | |
| CN104204798A (zh) | 膀胱癌的生物标志物和使用所述生物标志物的方法 | |
| JP2013532830A (ja) | 前立腺癌に関するバイオマーカー及びそれを使用する方法 | |
| JP2011515666A (ja) | トリプルネガティブ乳がんに関連するdna修復タンパク質およびその使用法 | |
| US20240044902A1 (en) | Methods for the detection and treatment of ovarian cancer | |
| WO2024107923A1 (en) | Methods for the detection and treatment of lung cancer | |
| US20220260585A1 (en) | Controlling Intersample Analyte Variability in Complex Biological Matrices | |
| US20180274037A1 (en) | Novel biomarkers for pancreatic diseases | |
| Han et al. | Development and validation of a decision tree classification model for the essential hypertension based on serum protein biomarkers | |
| WO2014153442A2 (en) | Methods and systems for treatment of ovarian cancer | |
| EP3295176A1 (en) | Biomarkers for detection of tuberculosis risk | |
| WO2016123058A1 (en) | Biomarkers for detection of tuberculosis risk | |
| KR20250039409A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| CN111763736B (zh) | 用于诊断甲状腺乳头状癌淋巴结转移的液体活检试剂盒 | |
| US20250116676A1 (en) | Phosphopeptide/phosphoprotein signature predicting basal-like breast cancer recurrence | |
| EP4630819A1 (en) | Protein biomarkers for prognosis of liver fibrosis | |
| HK40090190A (en) | Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof | |
| HK40026777B (en) | Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |